1-Year Outcomes After Transcatheter Edge-to-Edge Repair in Degenerative MR Stratified by Extent of Cardiac Damage
JACC: Cardiovascular Interventions · 2025-11 · 18 (21) · 2596-2611
DOI: 10.1016/j.jcin.2025.08.039 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-11. Verfasst von Abdullah Al-Abcha und 23 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Mitral Valve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The impact of extramitral cardiac damage (EMCD) in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for degenerative mitral regurgitation (DMR) is unknown. OBJECTIVES: The aim of this study was to understand M-TEER outcomes stratified by the extent of EMCD. METHODS: One-year outcomes from the randomized CLASP IID (Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial) trial (NCT03706833) in prohibitive surgical risk patients with 3+ or 4+ DMR were analyzed by baseline EMCD stages (stage 0, no EMCD; stage 1, left ventricular remodeling; stage 2, left atrial remodeling; stage 3, pulmonary hypertension and/or tricuspid regurgitation; stage 4, right ventricular dysfunction). RESULTS: The analysis included 211 patients: 53.1% in stages 0, 1, and 2 (n = 112), 13.3% in stage 3 (n = 28), and 33.6% in stage 4 (n = 71). Stages 0, 1, and 2 were combined because there were few patients in stage 0 (n = 3) and stage 1 (n = 1). At baseline, patients with more advanced cardiac damage had more comorbidities, lower functional and quality-of-life measures, and greater mitral regurgitation severity. One-year rates of clinical events among all stages were comparable for major adverse events (P = 0.343) and all-cause mortality (P = 0.644) and significantly different for heart failure hospitalization (P = 0.012). Patients in all stages achieved comparable echocardiographic and quality-of-life improvements at 1 year, including mitral regurgitation ≤1+ (P = 0.474), left ventricular diastolic (P = 0.619) and systolic (P = 0.676) volumes, and Kansas City Cardiomyopathy Questionnaire score (P = 0.335), with significant improvements from baseline (P < 0.05 vs baseline for all). CONCLUSIONS: Results from the CLASP IID trial demonstrate benefit of M-TEER in DMR patients across all EMCD stages, including stage 4, with low major adverse events and all-cause mortality and comparable significant improvements in echocardiographic and quality-of-life outcomes at 1 year.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic, Rochester, Minnesota, USA.
- University of Virginia Health System Hospital, Charlottesville, Virginia, USA.
- Klinikum der Universität München, Munich, Germany.
- Baylor Scott and White: The Heart Hospital, Plano, Texas, USA.
- Oregon Health & Science University, Portland, Oregon, USA.
- Cedars-Sinai Medical Center, Los Angeles, California, USA.
Zitieren
APA
Al-Abcha, A., Lim, D. S., Hausleiter, J., Smith, R. L., Zahr, F., Chadderdon, S., Makkar, R., Makar, M. M., von Bardeleben, R. S., Ruf, T. F., Gößler, T., Kipperman, R. M., Rassi, A. N., Ku, I. A., Nabauer, M., Szerlip, M., Wang, Z., Goldman, S., Hawthorne, K. M., …, & CLASP IID Pivotal Trial Investigators (2025). 1-Year Outcomes After Transcatheter Edge-to-Edge Repair in Degenerative MR Stratified by Extent of Cardiac Damage. JACC: Cardiovascular Interventions, 18(21), 2596-2611. https://doi.org/10.1016/j.jcin.2025.08.039
Vancouver
Al-Abcha A, Lim DS, Hausleiter J, Smith RL, Zahr F, Chadderdon S, et al. 1-Year Outcomes After Transcatheter Edge-to-Edge Repair in Degenerative MR Stratified by Extent of Cardiac Damage. JACC: Cardiovascular Interventions. 2025;18(21):2596-2611. doi:10.1016/j.jcin.2025.08.039
BibTeX
@article{AlAbcha2025,
author = {Al-Abcha, Abdullah and Lim, D Scott and Hausleiter, Jörg and Smith, Robert L and Zahr, Firas and Chadderdon, Scott and Makkar, Raj and Makar, Moody M and von Bardeleben, Ralph Stephan and Ruf, Tobias Friedrich and Gößler, Theresa and Kipperman, Robert M and Rassi, Andrew N and Ku, Ivy A and Nabauer, Michael and Szerlip, Molly and Wang, Zuyue and Goldman, Scott and Hawthorne, Katie M and Koulogiannis, Konstantinos and Marcoff, Leo and Gillam, Linda D and Guerrero, Mayra E and CLASP IID Pivotal Trial Investigators, CLASP IID Pivotal Trial Investigators},
title = {1-Year Outcomes After Transcatheter Edge-to-Edge Repair in Degenerative MR Stratified by Extent of Cardiac Damage},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {21},
pages = {2596--2611},
doi = {10.1016/j.jcin.2025.08.039}
}
EUVIMED